Early Empagliflozin Doesn't Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI
(UPDATED) Neutral findings for another SGLT2 inhibitor, after the “soft” success of DAPA-MI, are a rare disappointment for this class.
Source: tctmd.com
📰 Nicole Bart News
Nicole Bart News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nicole Bart. Real-time updates on events, politics, business and more.
ChatGPT et al? Not So Fast, Say Journal Editors
Artificial intelligence tools are already changing scientific publishing, but oversight is questionable and concerns abound.
Source: tctmd.com